MSC-derived extracellular vesicles: Precision miRNA delivery for overcoming cancer therapy resistance
Regenerative Therapy · 2025-06 · 29 · 303-318
DOI: 10.1016/j.reth.2025.03.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Regenerative Therapy, 2025-06. Verfasst von Ahsas Goyal und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Research, GLA University, Mathura, UP, India. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 239 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Cancer remains a prominent worldwide health concern, presenting existing therapies with frequent difficulties, including major toxicity, limited effectiveness, and treatment resistance emergence. These issues highlight the necessity for novel and enhanced remedies. Exosomes, tiny extracellular vesicles that facilitate intercellular communication, have attracted interest for their potential medicinal applications. Carrying a variety of molecules, including microRNAs, small interfering RNAs, long non-coding RNAs, proteins, lipids, and DNA, these vesicles are positioned as promising cancer treatment options. Current studies have increasingly investigated the capacity of microRNAs as a strategic approach for combating malignancy. Mesenchymal stem cells (MSC) are recognized for their aptitude to augment blood vessel formation, safeguard against cellular death, and modulate immune responses. Consequently, researchers examine exosomes derived from MSCs as a safer, non-cellular choice over therapies employing MSCs, which risk undesirable differentiation. The focus is shifting towards employing miRNA-encapsulated exosomes sourced from MSCs to target and heal cancerous cells selectively. However, the exact functions of miRNAs within MSC-derived exosomes in the context of cancer are still not fully understood. Additional exploration is necessary to clarify the role of these miRNAs in malignancy progression and to pinpoint viable therapeutic targets. This review offers a comprehensive examination of exosomes derived from mesenchymal stem cells, focusing on the encapsulation of miRNAs, methods for enhancing cellular uptake and stability, and their potential applications in cancer treatment. It also addresses the difficulties linked to this methodology and considers future avenues, including insights from current clinical oncology research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Pharmaceutical Research, GLA University, Mathura, UP, India.
- Department of Pharmaceutical Sciences, Pharmacy Program, Batterjee Medical College, P.O. Box 6231, Jeddah, 21442, Saudi Arabia.
- Department of Biotechnology, Graphic Era (Deemed to be University), Clement Town, 248002, Dehradun, India.
- Department of Chemistry and Biochemistry, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India.
- Department of Applied Sciences-Chemistry, NIMS Institute of Engineering & Technology, NIMS University Rajasthan, Jaipur, India.
- Department of CHEMISTRY, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, India.
Zitieren
APA
Goyal, A., Afzal, M., Goyal, K., Ganesan, S., Kumari, M., Sunitha, S., Dash, A., Saini, S., Rana, M., Gupta, G., Ali, H., Wong, L. S., Kumarasamy, V., & Subramaniyan, V. (2025). MSC-derived extracellular vesicles: Precision miRNA delivery for overcoming cancer therapy resistance. Regenerative Therapy, 29, 303-318. https://doi.org/10.1016/j.reth.2025.03.006
Vancouver
Goyal A, Afzal M, Goyal K, Ganesan S, Kumari M, Sunitha S, et al. MSC-derived extracellular vesicles: Precision miRNA delivery for overcoming cancer therapy resistance. Regenerative Therapy. 2025;29:303-318. doi:10.1016/j.reth.2025.03.006
BibTeX
@article{Goyal2025,
author = {Goyal, Ahsas and Afzal, Muhammad and Goyal, Kavita and Ganesan, Subbulakshmi and Kumari, Mukesh and Sunitha, S and Dash, Aniruddh and Saini, Suman and Rana, Mohit and Gupta, Gaurav and Ali, Haider and Wong, Ling Shing and Kumarasamy, Vinoth and Subramaniyan, Vetriselvan},
title = {MSC-derived extracellular vesicles: Precision miRNA delivery for overcoming cancer therapy resistance},
journal = {Regenerative Therapy},
year = {2025},
volume = {29},
pages = {303--318},
doi = {10.1016/j.reth.2025.03.006}
}
EUVIMED